Atul Ambekar

Professor

biography

Dr. Atul Ambedkar is Additional professor in National Drug Dependence Treatment centre,New delhi. He is awarded the best prestigious Vidyasagar Gold Medal for best PG student in department of psychiatry from All india medical sciences,New delhi. His research interests are Drug Policies and Programs,Opioid Substitution Therapy (OST) and Epidemiology of drug use and HIV.

 

Area of Interest

1) Opioid Substitution Therapy (OST)
2) Epidemiology of drug use and HIV

3) Drug Policies and Programs


top publication

ï‚·1) Bhad R, Dayal P, Kumar S and Ambekar A, “The drug ketamine: a double edged sword for mental health professionals” J Subst Use (Accepted for publication)
ï‚· 2) Varshney M, Ambekar A, Lal R, Yadav D, Rao R, Mishra AK, “Brief Interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: A prospective study from India”, Addictive Disorders and Their Treatment, (Accepted for Publication)
ï‚· 3) Ambekar A, Rao R, Agrawal A, Mishra AK, Kishore K, Mukherjee D, Albertin C, “Pattern of drug use and associated behaviours among female injecting drug users from northeast India: a multi-centric, cross-sectional, comparative study”, Substance Use and Misuse, (Accepted for Publication)
ï‚· 4) Qureshi R, Jain R, Ambekar A, Mishra AK, “Association of ANKK I polymorphism with comorbid alcohol and nicotine dependence: A pilot study from a tertiary care treatment center in North India”. Indian Journal of Medical Research, (Accepted for Publication)
ï‚· 5) Ambekar A, Rao R, Mishra AK, Agrawal A, “Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs”, Drug Alcohol Rev. 2014 Oct 10. doi: 10.1111/dar.12208
ï‚·6) Bhad R, Ambekar A, and Dayal P, “The lizard: an unconventional psychoactive substance?”, Journal of Substance Use, Early Online: 1–2, DOI: 10.3109/14659891.2014.987836
ï‚· 7) Shrigopal Goyal, Atul Ambekar, Rajat Ray. “Ketamine Dependence in an Anesthesiologist: An Occupational Hazard?” Indian Journal of Psychological Medicine, Jul - Sep 2014; Vol 36; 3
ï‚· 8) Atul Ambekar, Ravindra Rao, Anan pun, Suresh Kumar, Kunal Kishore (2013), “The trajectory of Methadone Maintenance Treatment in Nepal”, International Journal of Drug Policy 2013 Jul 8. doi:pii: S0955-3959(13)00094-7. 10.1016/j.drugpo.2013.06.001
ï‚· 9) Atul Ambekar, Ravindra Rao, Alok Agrawal (2013). “India’s National Narcotic Drugs and Psychotropic Substances Policy 2012: A 20th Century Document in 21st Century.” International Journal of Drug Policy 2013 Jul;24(4):374-5
ï‚· 10) Rao R, Agrawal A, Kishore K, Ambekar A (2013). “Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning.” Bulletin of the World Health Organisation, Volume 91, Number 2, February 2013, doi: 10.2471/BLT.12.111815
ï‚· 11) Prasad P, Ambekar A, Vaswani M, Case–control association analysis of Dopamine receptor polymorphisms in alcohol dependence: a pilot study in Indian males, BMC Research Notes 2013, 6:418
ï‚· 12)Rizwana Quraishi, Raka Jain, Atul Ambekar (2013), “The Use of Dried Blood Spot Samples in Screening Drugs of Abuse” Pharmacology & Pharmacy, 2013, 4 (2); 152
13) Atul Ambekar, Aditya Pawar, ¡§Low Dead-Space Syringes for HIV prevention among people who inject drugs: Interesting, but a much stronger case is required.¡¨ International Journal of Drug Policy,. 2012 Nov 2. pii: S0955-3959(12)00149-1. doi: 10.1016/j.drugpo.2012.09.009.
„14 ) h Singh RR, Ambekar A, ¡§Opioid substitution treatment in a public health setting: A collaboration between hospitals and NGOs in the Punjab¡¨. International Journal of Drug Policy, 23 (2012) 169¡V 171
„15) h Ravindra Rao, Atul Ambekar, Seema Yadav, Hem Sethi, Anju Dhawan, ¡§Slow-release oral morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India¡¨ Journal of Substance Use, 2011; Early Online:1¡V7 „h Larance B, Ambekar A, Azim T, Murthy P, Panda S, Degenhardt L, Mathers B, ¡§The availability, diversion and injection of pharmaceutical opioids in South Asia¡¨, Drug Alcohol Rev. 2011 May;30(3):246-54.